Product
Sofosbuvir + Daclatasvir
2 clinical trials
2 indications
Indication
Hepatitis CIndication
Substance Use DisorderClinical trial
Towards HCV Elimination: Evaluation of an Integrated Model of HCV Care Targeting People Who Inject Drugs in Hai Phong, VietnamStatus: Completed, Estimated PCD: 2020-11-30
Clinical trial
Pharmacokinetics, Safety, Efficacy and Acceptability Study of Daclatasvir/Sofosbuvir in Children Weighing 14-35 Kilograms With Chronic Hepatitis C Virus InfectionStatus: Recruiting, Estimated PCD: 2023-12-31